Planta Med 2004; 70(3): 263-265
DOI: 10.1055/s-2004-818920
Letter
© Georg Thieme Verlag Stuttgart · New York

Lipoxygenase Inhibition by Anadanthoflavone, a New Flavonoid from the Aerial Parts of Anadenanthera colubrina

Maria-Teresa Gutierrez-Lugo1 , Joshua D. Deschamps2 , Theodore R. Holman2 , Enrique Suarez3 , Barbara N. Timmermann1
  • 1Department of Pharmacology and Toxicology, Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Arizona, Tucson, Arizona, U.S.A.
  • 2Department of Chemistry and Biochemistry, University of California, Santa Cruz, California, U.S.A.
  • 3INTA, Instituto Nacional de Recursos Biológicos, Castellar, Buenos Aires, Argentina
This study was supported by the ICBG ”Bioactive Agents from Dryland Biodiversity of Latin America” grant 5 UO1 TW 00316-10 from the National Institutes of Health (NIH), The National Science Foundation (NSF) and the US Department of Agriculture (USDA) to B.N.T., NIH-GM56062-06 (T.R.H.), ACS-RPG-00-219-01-CDD (T.R.H.). The contents are solely the responsibilities of the authors and do not necessarily represent the official views of the NIH, NSF or USDA
Further Information

Publication History

Received: July 3, 2003

Accepted: November 29, 2003

Publication Date:
23 March 2004 (online)

Abstract

Chemical investigation of the aerial parts of Anadenanthera colubrina led to the isolation of a new flavonoid named anadanthoflavone (1), along with 11 known compounds: alnusenol, lupenone, lupeol, betulinic acid, α-amyrin, β-amyrin, β-sitosterol, stigmasterol, apigenin, 4-hydroxybenzoic acid and cinnamic acid. The isolated compounds were evaluated for their inhibitory activity on human platelet 12-lipoxygenase (12-hLO), human reticulocyte 15-lipoxygenase (15-hLO) and soybean lipoxygenase-1 (15-sLO). Compound 1 was found to be active against 12-hLO and 15-hLO with IC50 values of 13 ± 3 μM and 17 ± 3 μM, respectively. Apigenin selectively inhibited the activity of 15-hLO (IC50 : 4.0 ± 1 μM), while lupenone, lupeol and α-amyrin were found active against 15-sLO (IC50 : 22 ± 3 μM, 35 ± 9 μM and 15 ± 3 μM, respectively).

References

  • 1 Delgobo C L, Gorin P A, Tischer C A, Iacomini M. The free reducing oligosaccharides of angico branco (Anadenanthera colubrina) gum exudate: an aid for structural assignments in the hetero-polysaccharide.  Carbohydr Res. 1999;  320 167-75
  • 2 Da Silva A G, Rodrigues J F, De Paula R C. Composition and rheological properties of exudate gum from Anadenanthera macrocarpa .  Polimeros: Ciencia e Tecnologia. 1998;  8 34-40
  • 3 De Paula R C, Budd P M, Rodrigues J F. Characterization of Anadenanthera macrocarpa exudate polysaccharide.  Polymer International. 1997;  44 55-60
  • 4 Bongiorno de Pfirter G M, Mandrile E L. Active principles having hallucinogenic effects. II. Bufotenine and other tryptamines. Their presence in Anadenanthera peregrina (L.) Spegazzini (Leguminosae).  Acta Farm Bonaerense. 1983;  2 47-54
  • 5 Timmermann B N, Wächer G A, Valcic S, Hutchinson B, Henzel J, Casler C. et al . The Latin American ICBG: The first five years.  Pharm Biol. 1999;  37 (Suppl. J. Rosenthal, Ed.) 35-54
  • 6 Gardner H W. Recent investigations into the lipoxygenase pathway of plants.  Biochim Biophys Acta. 1991;  1084 221-39
  • 7 Solomon E I, Zhou J, Neese F, Pavel E G. New Insights from spectroscopy into the structure/function relationships of lipoxygenases.  Chem Biol. 1997;  4 795-808
  • 8 Nadler J L, Natarajan R. Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states. PCT Int. Appl 1996: 94 p
  • 9 Steele V E, Holmes C A, Hawk E T, Kopelovich L, Lubet R A, Crowell J A. et al . Lipoxygenase inhibitors as potential cancer chemopreventives.  Cancer Epidemmiol Biomarkers Prev. 1999;  8 467-83
  • 10 Brash A R. Lipoxygenases: occurrence, functions, catalysis and acquisition of substrate.  J Biol Chem. 1999;  274 23 679-82
  • 11 Whitman S, Gezginci M, Timmermann B, Holman T. Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase.  J Med Chem. 2002;  45 2659-61
  • 12 Sailer E R, Schweizer S, Boden S E, Ammon H PT, Safayhi H. Characterization of an acetyl-11-keto-β-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling.  Eur J Biochem. 1998;  256 364-8
  • 13 Amagata T, Whitman S, Johnson C, Stessman C, Loo C P, Lobkovsky E. et al . Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases.  J Nat Prod. 2003;  66 230-5
  • 14 Sadik C D, Sies H, Schewe T. Inhibition of 15-lipoxygenase by flavonoids: structure-activity relations and mode of action.  Biochem Pharmacol. 2003;  65 773-81
  • 15 You K M, Jong H -G, Kim H P. Inhibition of cyclooxygenase/lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants.  Arch Pharm Res. 1999;  22 18-24
  • 16 Kitanaka S, Takido M. Studies on the constituents of the leaves of Cassia torosa Cav. II. The structure of two novel favones, torosaflavone C and D.  Chem Pharm Bull. 1991;  39 3254-7
  • 17 Kitanaka S, Takido M. Demethyltorosaflavones C and D from Cassia nomame .  Phytochemistry. 1992;  31 2927-9
  • 18 Holman T R, Zhou J, Solomon E I. Spectroscopic and functional characterization of a ligand coordination mutant of soybean lipoxygenase: first coordination sphere analogue of human 15-lipoxygenase.  J Am Chem Soc. 1998;  120 12 564-72

Barbara N. Timmermann, Ph. D.

Department of Pharmacology and Toxicology

Division of Medicinal and Natural Products Chemistry

College of Pharmacy

University of Arizona

1703 E. Mabel Street

Tucson

Arizona 85721-0207

U.S.A.

Phone: +1-520-626-2481

Fax: +1-520-626-2515

Email: btimmer@pharmacy.arizona.edu